INCY.NASDAQIncyte CORP

Form 4: Baker Bros. Advisors Report Changes in Beneficial Ownership of Incyte Corp (INCY)

Sentiment:

SEC Form 4


Baker Bros. Advisors LP and related entities, including Julian and Felix Baker, reported changes in their beneficial ownership of Incyte Corp common stock due to the issuance of shares in lieu of director retainer fees.

Summary

  • Baker Bros. Advisors LP and related entities filed a Form 4 detailing changes in their beneficial ownership of Incyte Corp (INCY) common stock.
  • The reported transaction involves the acquisition of 496 shares of common stock by Julian C. Baker on September 30, 2024, as compensation for director retainer fees.
  • These shares were issued under Incyte's Amended and Restated 2010 Stock Incentive Plan.
  • Julian C. Baker serves on Incyte's board as a representative of 667, L.P. and Baker Brothers Life Sciences, L.P.
  • The filing also reflects indirect beneficial ownership by various Baker Bros. entities and individuals.
  • After the reported transactions, Baker Bros. entities and related parties beneficially own millions of shares of Incyte common stock, held directly and indirectly.
  • Julian C. Baker directly holds 278,773 shares, and Felix J. Baker directly holds 281,190 shares.
  • The filing includes disclaimers of beneficial ownership except to the extent of pecuniary interest.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The filing indicates continued insider ownership and alignment with shareholder interests, but it's a routine disclosure.

Positives

  • The acquisition of shares by a director demonstrates continued alignment with shareholder interests.
  • Baker Bros. Advisors LP and related entities maintain a substantial ownership stake in Incyte, reflecting their confidence in the company's prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC for insiders of publicly traded companies, providing transparency into their transactions and holdings. Baker Brothers are well known investors in the biotech space.

Comparison to Industry Standards

  • Form 4 filings are a standard regulatory requirement for company insiders, including directors and officers, as well as beneficial owners holding more than 10% of a company's stock.
  • The disclosure of indirect and direct ownership is consistent with SEC guidelines to ensure transparency.
  • The disclaimers of beneficial ownership, except to the extent of pecuniary interest, are common practice among investment advisors and fund managers to avoid undue attribution of ownership.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders.
  • The disclosure provides transparency to shareholders regarding insider transactions.

Key Dates

DateDescription
09/30/2024Date of transaction: Julian C. Baker acquired 496 shares of Incyte common stock in lieu of director retainer fees.
10/02/2024Date of filing: Form 4 filing date.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.